These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

812 related items for PubMed ID: 19620314

  • 21. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C, Yamada H, Shibata K, Maeda N, Yoshida S, Wajjwalku W, Ohara N, Yamada T, Kinoshita T, Yoshikai Y.
    J Infect Dis; 2008 May 01; 197(9):1263-74. PubMed ID: 18422438
    [Abstract] [Full Text] [Related]

  • 22. Chimaeric protein improved immunogenicity compared with fusion protein of Ag85B and ESAT-6 antigens of Mycobacterium tuberculosis.
    Xu Y, Wang B, Chen J, Wang Q, Zhu B, Shen H, Qie Y, Wang J, Wang H.
    Scand J Immunol; 2006 Nov 01; 64(5):476-81. PubMed ID: 17032239
    [Abstract] [Full Text] [Related]

  • 23. Characterization of murine T-cell epitopes on mycobacterial DNA-binding protein 1 (MDP1) using DNA vaccination.
    Suzuki D, Nagata T, Eweda G, Matsumoto S, Matsumoto M, Tsujimura K, Koide Y.
    Vaccine; 2010 Feb 23; 28(8):2020-5. PubMed ID: 20188258
    [Abstract] [Full Text] [Related]

  • 24. Mutating the anchor residues associated with MHC binding inhibits and deviates CD8+ T cell mediated protective immunity against malaria.
    Dobaño C, McTague A, Sette A, Hoffman SL, Rogers WO, Doolan DL.
    Mol Immunol; 2007 Mar 23; 44(9):2235-48. PubMed ID: 17169429
    [Abstract] [Full Text] [Related]

  • 25. Identification of murine H2-Dd- and H2-Ab-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis.
    Suzuki M, Aoshi T, Nagata T, Koide Y.
    Infect Immun; 2004 Jul 23; 72(7):3829-37. PubMed ID: 15213124
    [Abstract] [Full Text] [Related]

  • 26. MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.
    Höhn H, Kortsik C, Zehbe I, Hitzler WE, Kayser K, Freitag K, Neukirch C, Andersen P, Doherty TM, Maeurer M.
    Scand J Immunol; 2007 May 23; 65(5):467-78. PubMed ID: 17444958
    [Abstract] [Full Text] [Related]

  • 27. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
    Geluk A, van den Eeden SJ, van Meijgaarden KE, Dijkman K, Franken KL, Ottenhoff TH.
    Vaccine; 2012 Dec 14; 30(52):7513-21. PubMed ID: 23103299
    [Abstract] [Full Text] [Related]

  • 28. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P, Majlessi L, Brosch R, Smith D, Bancroft G, Clark S, Williams A, Leclerc C, Cole ST.
    J Infect Dis; 2004 Jul 01; 190(1):115-22. PubMed ID: 15195250
    [Abstract] [Full Text] [Related]

  • 29. Identification of HLA-DR4-restricted T-cell epitope on MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis using MPT51 overlapping peptides screening and DNA vaccination.
    Wang LX, Nagata T, Tsujimura K, Uchijima M, Seto S, Koide Y.
    Vaccine; 2010 Feb 23; 28(8):2026-31. PubMed ID: 20188259
    [Abstract] [Full Text] [Related]

  • 30. Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guérin in purified protein derivative (PPD)-positive individuals.
    Silver RF, Wallis RS, Ellner JJ.
    J Immunol; 1995 May 01; 154(9):4665-74. PubMed ID: 7722319
    [Abstract] [Full Text] [Related]

  • 31. In Vivo Antigen Expression Regulates CD4 T Cell Differentiation and Vaccine Efficacy against Mycobacterium tuberculosis Infection.
    Clemmensen HS, Dube JY, McIntosh F, Rosenkrands I, Jungersen G, Aagaard C, Andersen P, Behr MA, Mortensen R.
    mBio; 2021 Apr 20; 12(2):. PubMed ID: 33879592
    [Abstract] [Full Text] [Related]

  • 32. Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein.
    Stukova MA, Sereinig S, Zabolotnyh NV, Ferko B, Kittel C, Romanova J, Vinogradova TI, Katinger H, Kiselev OI, Egorov A.
    Tuberculosis (Edinb); 2006 Apr 20; 86(3-4):236-46. PubMed ID: 16677861
    [Abstract] [Full Text] [Related]

  • 33. Mucosal delivery of microparticle encapsulated ESAT-6 induces robust cell-mediated responses in the lung milieu.
    Carpenter ZK, Williamson ED, Eyles JE.
    J Control Release; 2005 May 05; 104(1):67-77. PubMed ID: 15866335
    [Abstract] [Full Text] [Related]

  • 34. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
    Radosevic K, Wieland CW, Rodriguez A, Weverling GJ, Mintardjo R, Gillissen G, Vogels R, Skeiky YA, Hone DM, Sadoff JC, van der Poll T, Havenga M, Goudsmit J.
    Infect Immun; 2007 Aug 05; 75(8):4105-15. PubMed ID: 17526747
    [Abstract] [Full Text] [Related]

  • 35. Confirmation of Mycobacterium tuberculosis infection by flow cytometry after ex vivo incubation of peripheral blood T cells with an ESAT-6-derived peptide pool.
    Tesfa L, Koch FW, Pankow W, Volk HD, Kern F.
    Cytometry B Clin Cytom; 2004 Jul 05; 60(1):47-53. PubMed ID: 15221869
    [Abstract] [Full Text] [Related]

  • 36. Cryptic epitopes on the nicotinic acetylcholine receptor are recognized by autoreactive CD4+ cells.
    Bellone M, Ostlie N, Karachunski P, Manfredi AA, Conti-Tronconi BM.
    J Immunol; 1993 Jul 15; 151(2):1025-38. PubMed ID: 7687612
    [Abstract] [Full Text] [Related]

  • 37. Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection.
    Clemmensen HS, Knudsen NPH, Billeskov R, Rosenkrands I, Jungersen G, Aagaard C, Andersen P, Mortensen R.
    Front Immunol; 2020 Jul 15; 11():585359. PubMed ID: 33240275
    [Abstract] [Full Text] [Related]

  • 38. Identification of murine T-cell epitopes on low-molecular-mass secretory proteins (CFP11, CFP17, and TB18.5) of Mycobacterium tuberculosis.
    Eweda G, Suzuki D, Nagata T, Tsujimura K, Koide Y.
    Vaccine; 2010 Jun 23; 28(29):4616-25. PubMed ID: 20457290
    [Abstract] [Full Text] [Related]

  • 39. Expression mapping using a retroviral vector for CD8+ T cell epitopes: definition of a Mycobacterium tuberculosis peptide presented by H2-Dd.
    Aoshi T, Suzuki M, Uchijima M, Nagata T, Koide Y.
    J Immunol Methods; 2005 Mar 23; 298(1-2):21-34. PubMed ID: 15847794
    [Abstract] [Full Text] [Related]

  • 40. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge.
    Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, Locksley RM, Haynes L, Randall TD, Cooper AM.
    Nat Immunol; 2007 Apr 23; 8(4):369-77. PubMed ID: 17351619
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.